The Vaccine Expert Advisory Group of the World Health Organization (WHO) It recommended today that patients from certain groups at risk receive a third additional dose of anticovid vaccine, despite the fact that the agency had requested a moratorium on these booster inoculations in August.
Mexican Alejandro Cravioto, president of the WHO Strategic Advisory Group of Experts (SAGE), made this announcement after the meeting held last week by this body, in which vaccination strategies against the COVID-19 and other diseases, such as malaria or polio.
The experts also recommended that the international community set a goal of vaccinating 70 percent of the world’s population against COVID-19 by mid-2022.
“It is a much higher percentage than we thought before, but given the development of the pandemic and the availability of new vaccines for younger age groups, it is a possible target,” said the president of SAGE.
About the third dose (or second in the case of the Johnson & Johnson single-dose vaccine), in principle it should be administered to people with a “severely or moderately compromised immune system”Cravioto stressed at a press conference.
The Mexican expert clarified that this recommendation applies to all vaccines that the WHO has approved for emergency use against COVID-19: Pfizer-BioNTech, Moderna, AstraZeneca, Johnson & Johnson, Sinopharm y Sinovac.
In the coming days, the one from the Indian laboratory Bharat will surely join, according to Cravioto.
The green light to a third dose, limited to certain groups, comes after the WHO asked in August not to administer booster doses until the end of September given the persistent inequality in the distribution of anticovid vaccines, a term that was extended, weeks later , until January 2022.